BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 8621483)

  • 1. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
    Smit L; van der Horst G; Borst J
    J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2.
    Ichiba T; Kuraishi Y; Sakai O; Nagata S; Groffen J; Kurata T; Hattori S; Matsuda M
    J Biol Chem; 1997 Aug; 272(35):22215-20. PubMed ID: 9268367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.
    Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM
    J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins.
    Tanaka S; Morishita T; Hashimoto Y; Hattori S; Nakamura S; Shibuya M; Matuoka K; Takenawa T; Kurata T; Nagashima K
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3443-7. PubMed ID: 7512734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.
    Harmer SL; DeFranco AL
    Mol Cell Biol; 1997 Jul; 17(7):4087-95. PubMed ID: 9199344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins.
    Ingham RJ; Krebs DL; Barbazuk SM; Turck CW; Hirai H; Matsuda M; Gold MR
    J Biol Chem; 1996 Dec; 271(50):32306-14. PubMed ID: 8943292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
    J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Shc, Cbl, Grb2, and Sos following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary rat hepatocytes.
    Park R; Kim DH; Kim MS; So HS; Chung HT; Kwon KB; Ryu DG; Kim BR
    Biochem Biophys Res Commun; 1998 Dec; 253(3):577-81. PubMed ID: 9918770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
    Odai H; Sasaki K; Iwamatsu A; Nakamoto T; Ueno H; Yamagata T; Mitani K; Yazaki Y; Hirai H
    Blood; 1997 Apr; 89(8):2745-56. PubMed ID: 9108392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Vav and Ras through the nerve growth factor and B cell receptors by different kinases.
    Melamed I; Patel H; Brodie C; Gelfand EW
    Cell Immunol; 1999 Feb; 191(2):83-9. PubMed ID: 9973529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
    Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
    Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS.
    Ravichandran KS; Lorenz U; Shoelson SE; Burakoff SJ
    Mol Cell Biol; 1995 Feb; 15(2):593-600. PubMed ID: 7529871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G.
    Reedquist KA; Fukazawa T; Panchamoorthy G; Langdon WY; Shoelson SE; Druker BJ; Band H
    J Biol Chem; 1996 Apr; 271(14):8435-42. PubMed ID: 8626543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets of CD45 in B cell antigen receptor signal transduction.
    Pao LI; Bedzyk WD; Persin C; Cambier JC
    J Immunol; 1997 Feb; 158(3):1116-24. PubMed ID: 9013950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
    Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
    J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Networks of interaction of p120cbl and p130cas with Crk and Grb2 adaptor proteins.
    Khwaja A; Hallberg B; Warne PH; Downward J
    Oncogene; 1996 Jun; 12(12):2491-8. PubMed ID: 8700507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.